The WTO waiver battle over Covid jab IP rights
Sudden US backing for a global waiver on patent protections for COVID-19 vaccines offers hope to poor nations struggling for doses—but the big pharma industry thinks the notion misguided.
- Next story Facebook Ducks the Big Issue
- Previous story Tell Us: Do You Want Children?
Explore more
- Consumer health: What do you know about Lou Gehrig’s Disease?
May is ALS Awareness Month, which makes this a good time to... - Trial of existing antibiotic for treating Staphylococcus aureus bacteremia begins
A clinical trial to test the antibiotic dalbavancin for safety and efficacy... - Pregnancy increases kidney stone risk, study finds
Though researchers have long known that several physiological and anatomical changes occur... - Cal Survived Covid. Now, Back to Its Usual Problems
The university conducted tens of thousands of coronavirus tests, aborted the football... - Black Rob, Rapper Known for His Hit Single ‘Whoa!,’ Dies at 52
A star for Bad Boy Records after the Notorious B.I.G.’s death, the... - Trump DOJ requested data on 73 phone numbers and 36 email addresses from Apple
The Department of Justice sent a broad request in February 2018 to... - Medical costs another burden for burn victims from the bush
Living away from community and country, Aboriginal families of children with severe... - The Covid-19 origin story has massive political consequences
- You can pass COVID to your cat, study finds
(HealthDay)—Not even your beloved feline is safe from COVID-19. - Interim study suggests oral TXA is equally effective in preventing blood loss in joint replacement
Interim results of a study conducted by researchers at Hospital for Special...